JamesR.GossageMD
Pulmonology • Augusta, GACritical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine
Professor, Medicine, Medical College of Georgia at Georgia Health Sciences University
Dr. Gossage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1499 Walton Way
Ste 1400
Augusta, GA 30901Phone+1 706-721-4501Fax+1 706-721-1459
Education & Training
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1984 - 1987
Rush Medical College of Rush University Medical CenterClass of 1984
Certifications & Licensure
GA State Medical License 1994 - 2025
TN State Medical License 1988 - 1994
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding Start of enrollment: 2006 Oct 01
- Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Start of enrollment: 2010 Apr 08
- North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Arteriovenous malformation from a patient with JP-HHT harbours two second-hit somatic DNA alterations in.Evon DeBose-Scarlett, Andrew K Ressler, Cassi Friday, Kara K Prickett, James W Roberts
Journal of Medical Genetics. 2025-03-20 - Brain and lung arteriovenous malformation rescreening practices for children and adults with hereditary hemorrhagic telangiectasia.Lauren A Beslow, Helen Kim, Steven W Hetts, Felix Ratjen, Marianne S Clancy
Orphanet Journal of Rare Diseases. 2024-11-09 - 2 citationsSomatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.Evon DeBose-Scarlett, Andrew K Ressler, Carol J Gallione, Gonzalo Sapisochin Cantis, Cassi Friday
American Journal of Human Genetics. 2024-10-03
Other
- Pulmonary arteriovenous malformations: Diagnostic evaluationGossage JR
http://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-diagnostic-evaluation
UpToDate, Wolters Kluwer Health - 2012-01-16 - Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical featuresGossage JR
http://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-epidemiology-etiology-patholo
UpToDate, Wolters Kluwer Health - 2012-01-16 - Pulmonary arteriovenous malformations: TreatmentGossage JR
http://www.uptodate.com/contents/pulmonary-arteriovenous-malformations-treatment
UpToDate, Wolters Kluwer Health - 2012-01-16
Grant Support
- A Phase II/III randomized, placebo controlled, double blind study to evaluate the effects of up to 24 weeks of low dose pazopanib on HHT related epistaxis and anemia. IND#144808 June 25, 2020HHT FOUNDATION INTERNATIONAL, INC.2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
